Abstract:
Pharmaceutical compositions containing the azo dyes Direct Orange 26, Direct Red 23, Direct Red 24, Direct Red 26, and similar dyes, as well as the use of such azo dyes to inhibit the binding of a virus to the CD4 glycoprotein, in detecting or quantitating CD4-positive T4 lymphocytes, and in the protection against or treatment of viral infections.